We further determined that the paclitaxel resistant cancer cells with elevated Bcl-2 were more susceptible to a Nur77 peptide capable of converting Bcl-2 from an anti-apoptotic protein to a pro-apoptotic protein (Figures 3A-3C). The gene discussed is BCL2; the disease is cancer.